Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pulse Biosciences Inc.

    NASDAQ: PLSE · Real-Time Price · USD
    15.77
    -0.41 (-2.53%)
    At close: Jun 13, 2025, 3:59 PM
    15.77
    0.00%
    After-hours: Jun 13, 2025, 05:16 PM EDT

    Pulse Biosciences Statistics

    Share Statistics

    Pulse Biosciences has 67.27M shares outstanding. The number of shares has increased by 11.39% in one year.

    Shares Outstanding

    n/a
    		 67.27M

    Shares Change (YoY)

    n/a
    		 11.39%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 9.77%

    Shares Floating

    n/a
    		 12.56M

    Failed to Deliver (FTD) Shares

    n/a
    		 974

    FTD / Avg. Volume

    n/a
    		 0.52%

    Short Selling Information

    The latest short interest is 2.4M, so 3.57% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.4M

    Short % of Shares Out

    n/a
    		 3.57%

    Short % of Float

    n/a
    		 15.55%

    Short Ratio (days to cover)

    n/a
    		 15.76

    Valuation Ratios

    The PE ratio is -18.97 and the forward PE ratio is -34.4. Pulse Biosciences's PEG ratio is -4.17.

    PE Ratio

    n/a
    		 -18.97

    Forward PE

    n/a
    		 -34.4

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 30.8

    PB Ratio

    n/a
    		 8.85

    P/FCF Ratio

    n/a
    		 -27.88

    PEG Ratio

    n/a
    		 -4.17
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Pulse Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 11.88, with a Debt / Equity ratio of 0.08.

    Current Ratio

    n/a
    		 11.88

    Quick Ratio

    n/a
    		 11.88

    Debt / Equity

    n/a
    		 0.08

    Debt / EBITDA

    n/a
    		 -0.17

    Debt / FCF

    n/a
    		 -0.24

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-714,466.67

    Employee Count

    n/a
    		 75

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 31.09% in the last 52 weeks. The beta is 1.63, so Pulse Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.63

    52-Week Price Change

    n/a
    		 31.09%

    50-Day Moving Average

    n/a
    		 16.88

    200-Day Moving Average

    n/a
    		 17.78

    Relative Strength Index (RSI)

    n/a
    		 39.39

    Average Volume (20 Days)

    n/a
    		 189,061

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -56.26M

    Net Income

    n/a
    		 -53.59M

    EBITDA

    n/a
    		 -52.41M

    EBIT

    n/a
    		 -53.59M

    Earnings Per Share (EPS)

    n/a
    		 -0.92
    Full Income Statement

    Balance Sheet

    The company has 118.04M in cash and 8.9M in debt, giving a net cash position of 109.14M.

    Cash & Cash Equivalents

    n/a
    		 118.04M

    Total Debt

    n/a
    		 8.9M

    Net Cash

    n/a
    		 109.14M

    Retained Earnings

    n/a
    		 -390.5M

    Total Assets

    n/a
    		 133.38M

    Working Capital

    n/a
    		 113.15M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -36.34M and capital expenditures -125K, giving a free cash flow of -36.47M.

    Operating Cash Flow

    n/a
    		 -36.34M

    Capital Expenditures

    n/a
    		 -125K

    Free Cash Flow

    n/a
    		 -36.47M

    FCF Per Share

    n/a
    		 -0.62
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PLSE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for PLSE.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 43.4

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist